GGrantIndex
← Leaderboards

George F Wooten

University Of Virginia Charlottesville

$2,467,091
Attributed
$2,467,091
Total exposure
3
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200512
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$10,994,526 · 4

By mechanism

P50$10,380,557 · 3
U10$613,969 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Others in their field

Top investigators on “Parkinson'S Disease

Research focus

Parkinson'S DiseaseMitochondrial DnaDisease /Disorder EtiologyHuman SubjectFamily GeneticsHuman Genetic Material TagGene MutationEnglandActivities Of Daily LivingHealth SciencesConduct Clinical TrialsAwardDatabasesCenters Of Research ExcellenceClinical TrialsDisease AssociationBehaviorDiagnostic AccuracyAmericanEnrollmentDiagnosisDoctor Of PhilosophyDoctor Of MedicineDentistry

Grant awards (29)

Parkinson's Disease Neuroprotection Clinical Trial$48,048
U10 · FY2012 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$45,117
U10 · FY2011 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$72,641
U10 · FY2010 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$42,600
U10 · FY2010 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$51,389
U10 · FY2009 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$47,177
U10 · FY2008 · NS · contact PI
Mitochrondrial Etiologies of Parkinsons Disease$1,190,125
P50 · FY2007 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$50,237
U10 · FY2007 · NS · contact PI
Mitochrondrial Etiologies of Parkinsons Disease$1,254,155
P50 · FY2006 · NS · contact PI
Parkinson's Disease Neuroprotection Clinical Trial$9,600
U10 · FY2006 · NS · contact PI
Mitochrondrial Etiologies of Parkinsons Disease$1,267,448
P50 · FY2005 · NS
Mitochrondrial Etiologies of Parkinsons Disease$64,500
P50 · FY2005 · NS
Parkinson's Disease Neuroprotection Clinical Trial$29,600
U10 · FY2005 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$152,000
P50 · FY2004 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$1,148,361
P50 · FY2003 · NS
Parkinson's Disease Neuroprotection Clinical Trial$108,780
U10 · FY2003 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$1,134,015
P50 · FY2002 · NS
CORE--CLINICAL, MOLECULAR GENETICS &DATA MANAGEMENT$231,922
P50 · FY2002 · NS
CORE--CLINICAL, MOLECULAR GENETICS &DATA MANAGEMENT$231,922
P50 · FY2002 · NS
GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE$231,922
P50 · FY2002 · NS
GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE$231,922
P50 · FY2002 · NS
Parkinson's Disease Neuroprotection Clinical Trial$108,780
U10 · FY2002 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$44,992
P50 · FY2002 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$1,119,108
P50 · FY2001 · NS
CORE--CLINICAL, MOLECULAR GENETICS &DATA MANAGEMENT$231,922
P50 · FY2001 · NS
GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE$231,922
P50 · FY2001 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE$1,152,731
P50 · FY2000 · NS
CORE--CLINICAL, MOLECULAR GENETICS &DATA MANAGEMENT$230,796
P50 · FY2000 · NS
GENETIC EPIDEMIOLOGY OF PD--MITOCHONDRIAL INHERITANCE$230,794
P50 · FY2000 · NS